Cargando…

Fibroblast Growth Factor 23 and Mortality Among Prevalent Hemodialysis Patients in the Japan Dialysis Outcomes and Practice Patterns Study

INTRODUCTION: Elevated fibroblast growth factor 23 (FGF23) levels have been strongly associated with mortality in the predialysis and incident hemodialysis populations, but few studies have examined this relationship in a large cohort of prevalent hemodialysis patients and in particular among person...

Descripción completa

Detalles Bibliográficos
Autores principales:	Komaba, Hirotaka, Fuller, Douglas S., Taniguchi, Masatomo, Yamamoto, Suguru, Nomura, Takanobu, Zhao, Junhui, Bieber, Brian A., Robinson, Bruce M., Pisoni, Ronald L., Fukagawa, Masafumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609896/ https://www.ncbi.nlm.nih.gov/pubmed/33163716 http://dx.doi.org/10.1016/j.ekir.2020.08.013

Ejemplares similares

Serum total indoxyl sulfate and clinical outcomes in hemodialysis patients: results from the Japan Dialysis Outcomes and Practice Patterns Study
por: Yamamoto, Suguru, et al.
Publicado: (2020)

Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS)
por: Yamamoto, Suguru, et al.
Publicado: (2018)

Changes in Fibroblast Growth Factor 23 and Soluble Klotho Levels After Hemodialysis Initiation
por: Kawabata, Chiaki, et al.
Publicado: (2019)

Acute cardiac overload does not induce cardiac or skeletal expression of fibroblast growth factor 23 in rats
por: Fajol, Abul, et al.
Publicado: (2021)

Association of erythropoietin resistance and fibroblast growth factor 23 in dialysis patients: Results from the Japanese Dialysis Outcomes and Practice Patterns Study
por: Usui, Tomoko, et al.
Publicado: (2020)

Secondary hyperparathyroidism, weight loss, and longer term mortality in haemodialysis patients: results from the DOPPS
por: Komaba, Hirotaka, et al.
Publicado: (2021)

Importance of Simultaneous Evaluation of Multiple Risk Factors for Hemodialysis Patients’ Mortality and Development of a Novel Index: Dialysis Outcomes and Practice Patterns Study
por: Kanda, Eiichiro, et al.
Publicado: (2015)

A Retrospective Study on Erythropoiesis Stimulating Agent Dose Reducing Potential of an Anti‐Platelet Activation Membrane Dialyzer in Hemodialysis Patients
por: Kakuta, Takatoshi, et al.
Publicado: (2018)

Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention
por: Goto, Shunsuke, et al.
Publicado: (2008)

Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
por: Komaba, Hirotaka, et al.
Publicado: (2021)

Response to Letter to the Editor From Sumi et al: “Lower Bone Turnover and Skeletal PTH Responsiveness in Japanese Compared to European Patients Receiving Hemodialysis”
por: Jørgensen, Hanne Skou, et al.
Publicado: (2022)

Perceptions about the dialysis modality decision process among peritoneal dialysis and in-center hemodialysis patients
por: Zee, Jarcy, et al.
Publicado: (2018)

Optimizing the cost-effectiveness of treatment for chronic kidney disease-mineral and bone disorder
por: Goto, Shunsuke, et al.
Publicado: (2013)

International and Racial Differences in Mineral and Bone Disorder Markers and Treatments Over the First 5 Years of Hemodialysis in the Dialysis Outcomes and Practice Patterns Study
por: Chan, Kevin, et al.
Publicado: (2019)

Associations of employment status and educational levels with mortality and hospitalization in the dialysis outcomes and practice patterns study in Japan
por: Imanishi, Yasuo, et al.
Publicado: (2017)

Association of fibroblast growth factor 23 and α-klotho in hemodialysis patients during administration of ferric citrate hydrate: post hoc analysis of ASTRIO study
por: Ito, Kyoko, et al.
Publicado: (2021)

Impact of longer term phosphorus control on cardiovascular mortality in hemodialysis patients using an area under the curve approach: results from the DOPPS
por: Lopes, Marcelo Barreto, et al.
Publicado: (2020)

Changes in practice patterns in Japan from before to after JSDT 2013 guidelines on hemodialysis prescriptions: results from the JDOPPS
por: Tomo, Tadashi, et al.
Publicado: (2021)

Interleukin-6 receptor inhibition with tocilizumab in various renal involvements associated with multicentric Castleman's disease: a report of three cases
por: Komaba, Hirotaka, et al.
Publicado: (2008)

A Japanese approach for CKD-MBD
por: Yokoyama, Keitaro, et al.
Publicado: (2013)

Roles of PTH and FGF23 in kidney failure: a focus on nonclassical effects
por: Komaba, Hirotaka
Publicado: (2023)

Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan
por: Shigematsu, Takashi, et al.
Publicado: (2018)

Evaluation of ABCG2-mediated extra-renal urate excretion in hemodialysis patients
por: Ohashi, Yuki, et al.
Publicado: (2023)

Association between long-term efficacy of cinacalcet and parathyroid gland volume in haemodialysis patients with secondary hyperparathyroidism
por: Tanaka, Motoko, et al.
Publicado: (2008)

The Pituitary Is a Candidate Organ That Modulates Circulating Klotho Levels
por: Sato, Tetsuhiko, et al.
Publicado: (2018)

Association between serum iron markers, iron supplementation and cardiovascular morbidity in pre-dialysis chronic kidney disease
por: Hasegawa, Takeshi, et al.
Publicado: (2023)

Sex-Specific Differences in Hemodialysis Prevalence and Practices and the Male-to-Female Mortality Rate: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
por: Hecking, Manfred, et al.
Publicado: (2014)

Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study
por: Hamano, Takayuki, et al.
Publicado: (2022)

Reversed whole PTH/intact PTH ratio as an indicator of marked parathyroid enlargement: five case studies and a literature review
por: Komaba, Hirotaka, et al.
Publicado: (2008)

The Association between Dialysis Dose and Risk of Cancer Death in Patients Undergoing Hemodialysis: The Q-Cohort Study
por: Hara, Masatoshi, et al.
Publicado: (2020)

Mortality Trends After Transfer From Peritoneal Dialysis to Hemodialysis
por: Nadeau-Fredette, Annie-Claire, et al.
Publicado: (2022)

Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan—A Phase 2 Randomized Trial
por: Inaba, Masaaki, et al.
Publicado: (2021)

Use of Renin-Angiotensin System Inhibitors Is Associated with Reduction of Fracture Risk in Hemodialysis Patients
por: Yamamoto, Suguru, et al.
Publicado: (2015)

The Global Impact of the COVID-19 Pandemic on In-Center Hemodialysis Services: An ISN-Dialysis Outcomes Practice Patterns Study Survey
por: Aylward, Ryan, et al.
Publicado: (2021)

Control of severe hyperparathyroidism in dialysis patients with nodular hyperplasia
por: Fukagawa, Masafumi, et al.
Publicado: (2008)

The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism
por: Tanaka, Motoko, et al.
Publicado: (2008)

Prognostic Importance of Fibroblast Growth Factor-23 in Dialysis Patients
por: Akalin, Nilgül, et al.
Publicado: (2014)

Peritoneal Dialysis and Mortality, Kidney Transplant, and Transition to Hemodialysis: Trends From 1996-2015 in the United States
por: Sukul, Nidhi, et al.
Publicado: (2020)

Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism
por: Kato, Chihiro, et al.
Publicado: (2020)

Hepatitis C Prevalence, Incidence, and Treatment in Chinese Hemodialysis Patients: Results From the Dialysis Outcomes and Practice Patterns Study-China (2019–21)
por: Gan, Liangying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pkokjl53ppfkgg7g1lq28tn594